For research purposes only. Not for human consumption. For use by licensed researchers only.
The GHK-Cu / KPV / BPC-157 / TB-500 Blend is a comprehensive four-peptide research formulation combining copper tripeptide regeneration, anti-inflammatory tripeptide action, pentadecapeptide cytoprotection, and Thymosin Beta-4 fragment-mediated tissue repair. It represents one of the most multi-targeted regenerative peptide blends available for preclinical research.
Mechanism of Action
Each compound contributes distinct but complementary mechanisms: GHK-Cu modulates gene expression for collagen and antioxidant synthesis; KPV inhibits NF-κB to reduce inflammatory cytokines; BPC-157 promotes vascular remodeling and fibroblast migration; and TB-500 accelerates actin upregulation and cell motility — targeting inflammation resolution, cellular repair, and tissue remodeling simultaneously.
Research Applications
- Comprehensive multi-pathway regeneration research
- Combined anti-inflammatory and tissue repair studies
- Gut and systemic cytoprotection models
- Multi-target wound healing and scar reduction research
- Synergistic peptide interaction and mechanistic studies
Research Grade Peptide
| Compound | GHK-Cu / KPV / BPC-157 / TB-500 Blend |
| Strength | 25 mg / 10 mg / 10 mg / 10 mg |
| Vial Size | 6 mL |
| Vial Color | Clear |
| Form | Lyophilized Powder |
| Purity | >98% (HPLC verified) |
| Price | $250.00 |
This compound is provided strictly for in vitro and laboratory research. It has not been evaluated by the FDA and is not intended for diagnostic, therapeutic, or human use. Available to licensed researchers only.